GlassScriptPhysician profile
Angeline Johny
NPI 1578025417
$925.39
in general payments reported to CMS, 2019-2025
17 companies · $741 in 2025
The $741 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $184 · 2025: $741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $925.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $177.63 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Teleflex LLC | $161.90 | 2025 | Urolift |
| Boston Scientific Corporation | $114.48 | 2024-2025 | Accolade Sr, Moses, Lithoclast |
| Intuitive Surgical, INC. | $65.60 | 2024 | |
| Antares Pharma, INC. | $59.18 | 2025 | Xyosted |
| Ethicon US, LLC | $56.59 | 2024 | N/A |
| Tolmar, INC. | $44.60 | 2025 | Eligard, Jatenzo |
| Novartis Pharmaceuticals Corporation | $29.26 | 2025 | |
| Pfizer INC. | $28.15 | 2025 | |
| Progenics Pharmaceuticals, INC. | $27.26 | 2024 | |
| Endo USA, INC. | $27.05 | 2025 | Aveed, Xiaflex |
| Ferring Pharmaceuticals INC. | $25.08 | 2025 | Adstiladrin |
| Abbvie INC. | $23.15 | 2025 | |
| Abc Home Medical Supply, INC. | $23.10 | 2025 | |
| Accord Healthcare, INC. | $21.82 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $21.35 | 2025 | |
| Sumitomo Pharma America, INC. | $19.19 | 2025 | Orgovyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angeline Johny listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.